InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Fischer Laurent, Chairman & CEO. Officer active across 1 companies, notably Adverum Biotechnologies, Inc.. Aggregated, 5 disclosures have been published. Total volume traded: €60k. The latest transaction was disclosed on 20 April 2022 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations5 total
€25,62225,000 shares@ €1.024943.0% of flow
Common Stock
SEC:0001209191-22-025414:0·
Ideal exit: 15 Jan 2023 (T+270)
€16,94810,677 shares@ €1.5874100.0% of flow
Common Stock
SEC:0001209191-21-069099·
Ideal exit: 4 Sept 2022 (T+270)
€16,94810,677 shares@ €1.587428.5% of flow
Common Stock
SEC:0001209191-21-069099:0·
Ideal exit: 4 Sept 2022 (T+270)
0680,000 shares0
Common Stock
SEC:0001209191-21-050747·
0680,000 shares0
Common Stock
SEC:0001209191-21-050747:0·
5 of 5 declarations
About Fischer Laurent
Laurent Fischer is the CEO, President, and Director of Adverum Biotechnologies, Inc. He leads the company with a vision focused on innovation in the biotechnology field. His leadership is crucial for Adverum's growth, ensuring that the company remains at the forefront of therapeutic advancements.
